Harmony Return On Capital Employed from 2010 to 2025

HRMY Stock  USD 33.19  0.16  0.48%   
Harmony Biosciences Return On Capital Employed yearly trend continues to be fairly stable with very little volatility. Return On Capital Employed is likely to outpace its year average in 2025. During the period from 2010 to 2025, Harmony Biosciences Return On Capital Employed regression line of annual values had r-squared of  0.31 and arithmetic mean of (0.32). View All Fundamentals
 
Return On Capital Employed  
First Reported
2010-12-31
Previous Quarter
0.23155179
Current Value
0.24
Quarterly Volatility
0.50275237
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 48.6 M, Net Interest Income of 1.1 M or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.6, Dividend Yield of 0.0 or PTB Ratio of 3.12. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Return On Capital Employed Growth Pattern

Below is the plot of the Return On Capital Employed of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Return On Capital Employed historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Return On Capital Employed10 Years Trend
Slightly volatile
   Return On Capital Employed   
       Timeline  

Harmony Return On Capital Employed Regression Statistics

Arithmetic Mean(0.32)
Geometric Mean0.34
Coefficient Of Variation(158.89)
Mean Deviation0.38
Median(0.51)
Standard Deviation0.50
Sample Variance0.25
Range1.9772
R-Value0.55
Mean Square Error0.19
R-Squared0.31
Significance0.03
Slope0.06
Total Sum of Squares3.79

Harmony Return On Capital Employed History

2025 0.24
2024 0.23
2023 0.3
2022 0.2
2021 0.18
2020 0.0126
2019 -1.68

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Return On Capital Employed, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Capital Employed 0.23  0.24 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.